Sulfated membrane adsorbers for economic pseudo-affinity capture of influenza virus particles

Biotechnology and Bioengineering

Volumn 103, Issue 6, 2009, Pages 1144-1154

  Opitz, Lars ^a   Lehmann, Sylvia ^a   Reichl, Udo ^a,b   Wolff, Michael W ^a,b  

^a MAX PLANCK INSTITUTE FOR DYNAMICS OF COMPLEX TECHNICAL SYSTEMS   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Influenza virus; Membrane adsorber; Pseudo affinity chromatography; Sulfated cellulose; Vaccine purification

Indexed keywords

ADSORBERS; CAPTURE CELLS; CATION EXCHANGE MEMBRANES; CELLULOSE MEMBRANES; CONVENTIONAL METHODS; DOWNSTREAM-PROCESSING; INFLUENZA VACCINES; INFLUENZA VIRUS; MADIN-DARBY CANINE KIDNEY CELLS; MAMMALIAN CELLS; MDCK CELLS; MEMBRANE ADSORBER; NOVARTIS; NOVEL METHODS; PRODUCT RECOVERY; PSEUDO-AFFINITY CHROMATOGRAPHY; REPRODUCIBILITIES; RESPIRATORY TRACT; SULFATED CELLULOSE; UNIT OPERATION; VOLUMETRIC FLOW RATE;

ADSORPTION; AFFINITY CHROMATOGRAPHY; ANIMAL CELL CULTURE; CELL CULTURE; CELLULOSE; CHROMATOGRAPHIC ANALYSIS; COLUMN CHROMATOGRAPHY; DISEASE CONTROL; FLOW RATE; MAMMALS; MEMBRANES; POSITIVE IONS; PURIFICATION; VACCINES;

CELL MEMBRANES;

CELLULOSE; CELVAPAN; INFLUENZA VACCINE; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ARTICLE; CATION EXCHANGE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; FLOW RATE; INFLUENZA VIRUS A H1N1; NONHUMAN; VIRUS STRAIN;

ADSORPTION; ANIMALS; BIOTECHNOLOGY; CELL LINE; CELLULOSE; CHROMATOGRAPHY, AFFINITY; DOGS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; MEMBRANES; SULFATES;

ADSORPTION; CATIONS; CELLULOSE; CHROMATOGRAPHY; COLUMN CHROMATOGRAPHY; DISEASES; FLOW MEASUREMENT; MAMMALS; MEMBRANES; PURIFICATION; TISSUE CULTURE; VIRUSES;

MAMMALIA; ORTHOMYXOVIRIDAE;

EID: 68149137107     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.22345     Document Type: Article

References (44)

1. Boi C, Cattoli F, Facchini R, Sorci M, Sarti GC. 2006a. Adsorption of lectins on affinity membranes. J Membr Sci 273(1-2):12-19.
2. Boi C, Facchini R, Sorci M, Sarti GC. 2006b. Characterisation of affinity membranes for IgG separation. Desalination 199(1-3):544-546. (Pubitemid 44161344)
3. Brands R, Visser J, Medema, Palache AM, van Scharrenburg GJM. 1999. Inlfuvac: A safe Madin Darby canine kidney (MDCK) cell culture-based influenza vaccine. Dev Biol Stand 98:93-100.
4. Castilho LR, Anspach FB, Deckwer W-D. 2002. Comparison of affinity membranes for the purification of immunoglobulins. J Membr Sci 207(2):253-264.
5. Cattoli F, Boi C, Sorci M, Sarti G. 2006. Adsorption of pure recombinant MBP-fusion proteins on amylose affinity membranes. J Membr Sci 273:2-11. (Pubitemid 43227415)
6. Charcosset C. 2006. Membrane processes in biotechnology: An overview. Biotechnol Adv 24(5):482-492.
7. Czermak P, Grzenia DL, Wolf A, Carlson JO, Specht R, Han B, Wickramasinghe SR. 2008. Purification of the densonucleosis virus by tangential flow ultrafiltration and by ion exchange membranes. Desalination 224(1-3):23-27. (Pubitemid 351209295)
8. Genzel Y, Behrendt I, Konig S, Sann H, Reichl U. 2004. Metabolism of MDCK cells during cell growth and influenza virus production in largescale microcarrier culture. Vaccine 22(17-18):2202-2208. (Pubitemid 38626059)
9. Genzel Y, Fischer M, Reichl U. 2006. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture. Vaccine 24(16):3261-3272.
10. Gerdil C. 2003. The annual production cycle for influenza vaccine. Vaccine 21(16):1776-1779. (Pubitemid 36398372)
11. Ghosh R. 2002. Protein separation using membrane chromatography: Opportunities and challenges. J Chromatogr A 952(1-2):13-27. (Pubitemid 34266868)
12. Govorkova EA, Murti G, Meignier B, de Taisne C, Webster RG. 1996. African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses. J Virol 70(8):5519-5524. (Pubitemid 26240727)
13. Herrmann A, Korte T, Arnold K, Hillebrecht B. 1992. The influence of dextran sulfate on influenza A virus fusion with erythrocyte membranes. Antiviral Res 19(4):295-311.
14. Hosoya M, Balzarini J, Shigeta S, De Clercq E. 1991. Differential inhibitory effects of sulfated polysaccharides and polymers on the replication of various myxoviruses and retroviruses, depending on the composition of the target amino acid sequences of the viral envelope glycoproteins. Antimicrob Agents Chemother 35(12):2515-2520.
15. Kalashnikova I, Ivanova N, Tennikova T. 2008. Development of a strategy of influenza virus separation based on pseudoaffinity chromatography on short monolithic columns. Anal Chem 80(6):2188-2198.
16. Kalbfuß B, Genzel Y, Wolff M, Zimmermann A, Morenweiser R, Reichl U. 2007a. Harvesting and concentration of human influenza A virus produced in serum-free mammalian cell culture for the production of vaccines. Biotechnol Bioeng 97(1):73-85. (Pubitemid 46649757)
17. Kalbfuß B, Wolff M, Geisler L, Tappe A, Wickramasinghe R, Thom V, Reichl U. 2007b. Direct capture of influenza A virus from cell culture supernatant with Sartobind anion-exchange membrane adsorbers. J Membr Sci 299(1-2):251-260. (Pubitemid 46962913)
18. Kalbfuß B, Wolff M, Morenweiser R, Reichl U. 2007c. Purification of cell culture-derived human influenza A virus by size-exclusion and anion-exchange chromatography. Biotechnol Bioeng 96(5):932-944.
19. Kalbfuß B, Knochlein A, Krober T, Reichl U. 2008. Monitoring influenza virus content in vaccine production: Precise assays for the quantitation of hemagglutination and neuraminidase activity. Biologicals 36(3):145-161.
20. Karger A, Bettin B, Granzow H, Mettenleiter TC. 1998. Simple and rapid purification of alphaherpesviruses by chromatography on a cation exchange membrane. J Virol Methods 70(2):219-224. (Pubitemid 28132825)
21. Kistner O, Barrett P, Mundt W, Reiter M, Schober-Bendixen S, Eder G, Dorner F. 1999. A novel mammalian cell (Vero) derived influenza virus vaccine: Development, characterization and industrial scale production. Wiener klinische Wochenschrift 111(5):207-214. (Pubitemid 29148621)
22. Lee D-S, Kim B-M, Seol D-W. 2009. Improved purification of recombinant adenoviral vector by metal affinity membrane chromatography. Biochem Biophys Res Commun 378(3):640-644.
23. Lüscher-Mattli M, Glück R, Kempf C, Zanoni-Grassi M. 1993. A comparative study of the effect of dextran sulfate on the fusion and the in vitro replication of influenza A and B, Semliki Forest, vesicular stomatitis, rabies, Sendai, and mumps virus. Arch Virol 130(3):317-326.
24. Matthews JT. 2006. Egg-based production of influenza vaccine: 30 years of commercial experience. Bridge 36(3):17-24.
25. Mellado MCM, Curbelo D, Nobrega R, Castilho LR. 2007. Comparison of affinity membrane adsorbers for the purification of recombinant human erythropoietin (rhEPO). J Chem Technol Biotechnol 82(7):636-645. (Pubitemid 47215152)
26. O'Neil PF, Balkovic ES. 1993. Virus harvesting and affinity-based liquid chromatography. Nat Biotechnol 11(2):173-178. (Pubitemid 223010909)
27. Opitz L, Lehmann S, Zimmermann A, Reichl U, Wolff MW. 2007a. Impact of adsorbents selection on capture efficiency of cell culture derived human influenza viruses. J Biotechnol 131(3):309-317. (Pubitemid 47362429)
28. Opitz L, Salaklang J, Büttner H, Reichl U, Wolff MW. 2007b. Lectin-affinity chromatography for downstream processing of MDCK cell culture derived human influenza A viruses. Vaccine 25(5):939-947. (Pubitemid 44856117)
29. Opitz L, Zimmermann A, Lehmann S, Genzel Y, Lübben H, Reichl U, Wolff MW. 2008. Capture of cell culture-derived influenza virus by lectins: Strain independent, but host cell dependent. J Virol Methods 154(1-2):61-68.
30. Palache AM, Brands R, van Scharrenburg GJM. 1997. Immunogenicity and reactogenicity of influenza subunit vaccines produced in MDCK cells or fertilized chicken eggs. J Infect Dis 176(s1):S20-S24. (Pubitemid 27315341)
31. Peixoto C, Ferreira TB, Sousa MQ, Carrondo MJT, Alves PM. 2008. Towards purification of adenoviral vectors based on membrane technology. Biotechnol Prog 24(6):1290-1296.
32. Platonova GA, Pankova GA, Il'ina IY, Vlasov GP, Tennikova TB. 1999. Quantitative fast fractionation of a pool of polyclonal antibodies by immunoaffinity membrane chromatography. J Chromatogr A 852(1):129-140.
33. Rabenstein DL. 2002. Heparin and heparan sulfate: Structure and function. Nat Prod Rep 19:312-331. (Pubitemid 34656777)
34. Ramalho-Santos J, Pedroso de Lima M. 2001. Fusion and infection of influenza and sendai viruses as modulated by dextran sulfate: A comparative study. Biosci Rep 21(3):293-304. (Pubitemid 34208252)
35. Sorci M, Boi C, Facchini R, Sarti GC. 2006. Purification of galacto-specific lectins by affinity membranes. Desalination 199(1-3):550-552. (Pubitemid 44161346)
36. Specht R, Han B, Wickramasinghe SR, Carlson JO, Czermak P, Wolf A, Reif O-W. 2004. Densonucleosis virus purification by ion exchange membranes. Biotechnol Bioeng 88(4):465-473. (Pubitemid 39536548)
37. Tree JA, Richardson C, Fooks AR, Clegg JC, Looby D. 2001. Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains. Vaccine 19(25-26):3444-3450. (Pubitemid 32710294)
38. Valeri A, Gazzei G, Morandi M, Pende B, Neri P. 1977. Large-scale purification of inactivated influenza vaccine using membrane molecular filtration. Cell Mol Life Sci 33(10):1402-1403. (Pubitemid 8194670)
39. WHO. 2007. Projected supply of pandemic influenza vaccine sharply increases. http://www.who.int/mediacentre/news/releases/2007/pr60/en/index.html; 2008/07/31. Geneva.
40. Wickramasinghe SR, Kalbfuß B, Zimmermann A, Thom V, Reichl U. 2005. Tangential flow microfiltration and ultrafiltration for human influenza A virus concentration and purification. Biotechnol Bioeng 92(2):199-208. (Pubitemid 41657882)
41. Wolff M, Reichl U. 2008. Downstream processing: From egg to cell culture derived influenza virus particles. Chem Eng Technol 6:1-13. (Pubitemid 351895178)
42. Wood JM, Schild GC, Newman RW, Seagroatt V. 1977. An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: Application for potency determinations of inactivated whole virus and subunit vaccines. J Biol Stand 5(3):237-247. (Pubitemid 8143405)
43. Wu C, Soh KY, Wang S. 2007. Ion-exchange membrane chromatography method for rapid and efficient purification of recombinant baculovirus and baculovirus gp64 protein. Hum Gene Ther 18(7):665-672. (Pubitemid 47187097)
44. Yamamoto S, Miyagawa E. Dynamic binding performance of large biomolecules such as gamma-globulin, viruses and virus-like particles on various chromatographic supports. In: Endo I, Nagamune T, Katoh S, Yonemoto T, editors. Bioseparation engineering. Nikko, Japan: Elsevier; 2000. p. 16.